Paper768802
Clonidine and the anti-parkinsonian response to L-DOPA or piribedil.
Shoulson I and 1 other. Neuropharmacology, 1976. Cited by 16 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Clonidine and the anti-parkinsonian response to L-DOPA or piribedil. Papers, record 768802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/768802
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Clonidine | Major topic |
| Levodopa | Major topic |
| Parkinson Disease | Major topic |
| Piperazines | Major topic |
| Piribedil | Major topic |
| Aged | |
| Carbidopa | |
| Clinical Trials as Topic | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Placebos |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27,521,014 | Antiparkinsonian Agents : Clinically Significant Drug Interactions and Adverse Effects, and Their Management. | CNS Drugs | 1998 | https://conductscience.org/library/papers/27521014 | PubMed |
| 16,787,845 | Restoration and putative protection in Parkinsonism. | Neurotox Res | 2000 | https://conductscience.org/library/papers/16787845 | PubMed |
| 16,362,627 | Influence of noradrenaline denervation on MPTP-induced deficits in mice. | J Neural Transm (Vienna) | 2006 | https://conductscience.org/library/papers/16362627 | PubMed |
| 12,835,093 | Effects of clonidine and alpha-adrenoceptor antagonists on motor activity in DSP4-treated mice II: interactions with apomorphine. | Neurotox Res | 2000 | https://conductscience.org/library/papers/12835093 | PubMed |
| 6,644,314 | Central catecholamine metabolism in vivo and the cognitive and motor deficits in Parkinson's disease. | J Neurol Neurosurg Psychiatry | 1983 | https://conductscience.org/library/papers/6644314 | PubMed |
| 6,337,612 | Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6337612 | PubMed |
| 6,267,192 | Neurochemical effects of some ergot derivatives: a basis for their antiparkinson actions. | J Neural Transm | 1981 | https://conductscience.org/library/papers/6267192 | PubMed |
| 3,998,775 | Clonidine in essential tremor: preliminary observations from an open trial. | J Neurol | 1985 | https://conductscience.org/library/papers/3998775 | PubMed |
| 196,226 | On the mode of action of clonidine: relationship between effects on behaviour and cyclic nucleotide content in mouse brain. | Naunyn Schmiedebergs Arch Pharmacol | 1977 | https://conductscience.org/library/papers/196226 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/768802
GET https://conductscience.org/api/papers/v1/768802/authors